Gene · 2041
Papers3,104
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 3,104
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The fusiform gyrus exhibits differential gene-gene co-expression in Alzheimer's disease. | Front Aging Neurosci | 2023 | 37255536 | PubTator, text mining | PubMed |
| Extended Exposure Topotecan Significantly Improves Long-Term Drug Sensitivity by Decreasing Malignant Cell Heterogeneity and by Preventing Epithelial-Mesenchymal Transition. | Int J Mol Sci | 2023 | 37239838 | PubTator, text mining | PubMed |
| Single-Cell Transcriptomics Reveals Evidence of Endothelial Dysfunction in the Brains of COVID-19 Patients with Implications for Glioblastoma Progression. | Brain Sci | 2023 | 37239234 | PubTator, text mining | PubMed |
| Dynamic Role of Exosome microRNAs in Cancer Cell Signaling and Their Emerging Role as Noninvasive Biomarkers. | Biology (Basel) | 2023 | 37237523 | PubTator, text mining | PubMed |
| Fractal dimension to characterize interactions between blood and lymphatic endothelial cells. | Phys Biol | 2023 | 37224822 | PubTator, text mining | PubMed |
| Non-cell-autonomous regulation of interneuron specification mediated by extracellular vesicles. | Sci Adv | 2023 | 37205765 | PubTator, text mining | PubMed |
| Targeting strategies for bone diseases: signaling pathways and clinical studies. | Signal Transduct Target Ther | 2023 | 37198232 | PubTator, text mining | PubMed |
| Role and mechanistic actions of protein kinase inhibitors as an effective drug target for cancer and COVID. | Arch Microbiol | 2023 | 37193831 | PubTator, text mining | PubMed |
| State of the Art of microRNAs Signatures as Biomarkers and Therapeutic Targets in Parkinson's and Alzheimer's Diseases: A Systematic Review and Meta-Analysis. | Biomedicines | 2023 | 37189731 | PubTator, text mining | PubMed |
| Structural and non-structural proteins in SARS-CoV-2: potential aspects to COVID-19 treatment or prevention of progression of related diseases. | Cell Commun Signal | 2023 | 37189112 | PubTator, text mining | PubMed |
| Promising immunotherapeutic targets in lung cancer based on single-cell RNA sequencing. | Front Immunol | 2023 | 37187731 | PubTator, text mining | PubMed |
| Binary and ternary complexes of epinephrine with alginate and biologically and environmentally relevant metal cations. | Front Chem | 2023 | 37179780 | PubTator, text mining | PubMed |
| Endotheliopathy in Acute COVID-19 and Long COVID. | Int J Mol Sci | 2023 | 37175942 | PubTator, text mining | PubMed |
| Multiplexing Biosensor for the Detection of Extracellular Vesicles as Biomarkers of Tissue Damage and Recovery after Ischemic Stroke. | Int J Mol Sci | 2023 | 37175644 | PubTator, text mining | PubMed |
| Bioengineered perfused human brain microvascular networks enhance neural progenitor cell survival, neurogenesis, and maturation. | Sci Adv | 2023 | 37163593 | PubTator, text mining | PubMed |
| Exome sequence analysis of rare frequency variants in Late-Onset Alzheimer Disease. | Metab Brain Dis | 2023 | 37162726 | PubTator, text mining | PubMed |
| Vitamins as regulators of calcium-containing kidney stones - new perspectives on the role of the gut microbiome. | Nat Rev Urol | 2023 | 37161031 | PubTator, text mining | PubMed |
| Overexpression of EphB6 and EphrinB2 controls soma spacing of cortical neurons in a mutual inhibitory way. | Cell Death Dis | 2023 | 37149633 | PubTator, text mining | PubMed |
| Combination of Novel Therapies and New Attempts in Anaplastic Thyroid Cancer. | Technol Cancer Res Treat | 2023 | 37122242 | PubTator, text mining | PubMed |
| Association of candidate genetic variants and circulating levels of ApoE/ApoJ with common neuroimaging features of cerebral amyloid angiopathy. | Front Aging Neurosci | 2023 | 37113571 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2041/papers?page=12